Targeting pathogenic monocytes

Targeting pathogenic monocytes

  • CN 102,209,557 A
  • Filed: 09/14/2009
  • Published: 10/05/2011
  • Est. Priority Date: 09/12/2008
  • Status: Active Application
First Claim
Patent Images

1. method, this method may further comprise the steps:

  • (a) use the function of adjusting IL-1 α

    or the agent of expression to the human experimenter;

    With(b) determine whether this using regulates monocytic amount of CD14+CD16+ or function among the experimenter.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×